Le Yu

Shantou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Triglyceride-glucose index demonstrates false-positive association with cardiometabolic multimorbidity progression in cardiometabolic disease patients: Observation and Mendelian randomization study.

Triglyceride-glucose index demonstrates false-positive association with cardiometabolic multimorbidity progression in cardiometabolic disease patients: Observation and Mendelian randomization study.

Journal: Medicine
Published: September 16, 2025

Chromosome X Open Reading Frame 38 (CXorf38) Is a Tumor Suppressor and Potential Prognostic Biomarker in Lung Adenocarcinoma: The First Characterization.

Chromosome X Open Reading Frame 38 (CXorf38) Is a Tumor Suppressor and Potential Prognostic Biomarker in Lung Adenocarcinoma: The First Characterization.

Journal: Proteomes
Published: March 11, 2025

Tumor Suppressor Genes with Segmental Duplications Are Prone to Somatic Deletions and Structural Variations.

Tumor Suppressor Genes with Segmental Duplications Are Prone to Somatic Deletions and Structural Variations.

Journal: Cancer research
Published: July 01, 2024

Probiotic-mediated tumor microenvironment reprogramming with protease-sensitive interleukin-15 and photothermal therapy.

Probiotic-mediated tumor microenvironment reprogramming with protease-sensitive interleukin-15 and photothermal therapy.

Journal: Cell reports. Medicine
Published: March 17, 2024

Cadherin 17 Nanobody-Mediated Near-Infrared-II Fluorescence Imaging-Guided Surgery and Immunotoxin Delivery for Colorectal Cancer.

Cadherin 17 Nanobody-Mediated Near-Infrared-II Fluorescence Imaging-Guided Surgery and Immunotoxin Delivery for Colorectal Cancer.

Journal: Biomaterials research
Published: January 29, 2024

Bortezomib and obatoclax for dual blockade of protein degradation pathways show synergistic anti-tumor effect in human acute T lymphoblastic leukemia cells

Bortezomib and obatoclax for dual blockade of protein degradation pathways show synergistic anti-tumor effect in human acute T lymphoblastic leukemia cells

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: May 10, 2019

AT‑101 induces G1/G0 phase arrest via the β‑catenin/cyclin D1 signaling pathway in human esophageal cancer cells.

AT‑101 induces G1/G0 phase arrest via the β‑catenin/cyclin D1 signaling pathway in human esophageal cancer cells.

Journal: Oncology reports
Published: January 15, 2018

ABT-263 induces G1/G0-phase arrest, apoptosis and autophagy in human esophageal cancer cells in vitro.

ABT-263 induces G1/G0-phase arrest, apoptosis and autophagy in human esophageal cancer cells in vitro.

Journal: Acta pharmacologica Sinica
Published: November 08, 2016

Synergistic anti-tumor effect of obatoclax and MG-132 in esophageal cancer cell line CaES-17

Synergistic anti-tumor effect of obatoclax and MG-132 in esophageal cancer cell line CaES-17

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: April 27, 2016

Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells.

Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells.

Journal: Oncotarget
Published: August 08, 2015

Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.

Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.

Journal: Cancer letters
Published: August 15, 2014

Celecoxib antagonizes the cytotoxic effect of carboplatin in human esophageal cancer cells

Celecoxib antagonizes the cytotoxic effect of carboplatin in human esophageal cancer cells

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: June 28, 2014
Showing 1-12 of 14

Last Updated: 09/26/2026